These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3882681)

  • 41. Classification and determination of pharmacodynamics of a new antihypoxidotic drug, vinconate, by pharmaco-EEG and psychometry.
    Saletu B; Grünberger J; Linzmayer L; Wittek R
    Arch Gerontol Geriatr; 1984 Jul; 3(2):127-46. PubMed ID: 6476974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effects of antidepressants on cognitive functions. Review of the literature].
    Amado-Boccara I; Gougoulis N; Poirier-Littré MF; Galinowski A; Lôo H
    Encephale; 1994; 20(1):65-77. PubMed ID: 8174512
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential effects of two types of antidepressants, amitriptyline and fluoxetine, on anorectal motility and visceral perception.
    Siproudhis L; Dinasquet M; Sébille V; Reymann JM; Bellissant E
    Aliment Pharmacol Ther; 2004 Sep; 20(6):689-95. PubMed ID: 15352918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The effect of a reserpine-like substance (tetrabenazine) followed by the administration of a tricyclic antidepressant (desmethylimipramine) on normal subjects].
    Goda G
    Encephale; 1972; 61(6):485-509. PubMed ID: 4578145
    [No Abstract]   [Full Text] [Related]  

  • 45. [A quantitative pharmaco-EEG study on psychotropic properties of cerebral metabolic enhancers: comparison between young and elderly healthy volunteers].
    Nobuhara K
    Seishin Shinkeigaku Zasshi; 1993; 95(5):392-416. PubMed ID: 8356168
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetic and dynamic studies with a new anxiolytic imidazo-pyridine alpidem utilizing pharmaco-EEG and psychometry.
    Saletu B; Grünberger J; Linzmayer L
    Int Clin Psychopharmacol; 1986 Apr; 1(2):145-64. PubMed ID: 2883214
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmaco-EEG profile of maroxepine: third example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs.
    Herrmann WM; Schärer E; Wendt G; Delini-Stula A
    Pharmacopsychiatry; 1991 Nov; 24(6):214-24. PubMed ID: 1812498
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitative pharmaco-electroencephalographic differentiation between the CNS effects of bromocriptine and imipramine, drugs with qualitatively different antidepressant properties.
    Yamadera H; Ferber G; Matejcek M; Pokorny R
    Pharmacopsychiatry; 1987 Mar; 20(2):54-9. PubMed ID: 3588662
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Visualizing central effects of S-adenosyl-L-methionine (SAMe), a natural molecule with antidepressant properties, by pharmaco-EEG mapping.
    Saletu-Zyhlarz GM; Anderer P; Linzmayer L; Semlitsch HV; Assandri A; Prause W; Hassan Abu-Bakr M; Lindeck-Pozza E; Saletu B
    Int J Neuropsychopharmacol; 2002 Sep; 5(3):199-215. PubMed ID: 12366873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Relation between blood levels and average quantitative EEG and psychometrically assessed pharmacodynamic changes following zotepine].
    Saletu B; Grünberger J; Anderer P; Chwatal K
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():45-55. PubMed ID: 1683340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative cognitive and psychomotor effects of single doses of Valeriana officianalis and triazolam in healthy volunteers.
    Hallam KT; Olver JS; McGrath C; Norman TR
    Hum Psychopharmacol; 2003 Dec; 18(8):619-25. PubMed ID: 14696021
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Objective measures in determining the central effectiveness of a new antihypoxidotic SL-76188: pharmaco-EEG, psychometric and pharmacokinetic analyses in the elderly.
    Grünberger J; Saletu B; Linzmayer L; Stöhr H
    Arch Gerontol Geriatr; 1982 Nov; 1(3):261-85. PubMed ID: 6764605
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
    Stark P; Hardison CD
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of lithium on vigilance, psychomotoric performance and mood.
    Müller-Oerlinghausen B; Hamann S; Herrmann WM; Kropf D
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Sep; 12(5):388-96. PubMed ID: 504346
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between EEG dynamics and pharmacokinetics of the benzodiazepine lormetazepam.
    Kurowski M; Ott H; Herrmann WM
    Pharmacopsychiatria; 1982 May; 15(3):77-83. PubMed ID: 6124982
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M; Tempero K; Kirby M; Thompson J
    Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A double-blind placebo-controlled investigation of the psychomotor profile of clopidogrel in healthy volunteers.
    Adam JK; Rmaih WN
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):507-9. PubMed ID: 19034035
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study.
    Lim KS; Kim JR; Choi YJ; Shin KH; Kim KP; Hong JH; Cho JY; Shin HS; Yu KS; Shin SG; Kwon OH; Hwang DM; Kim JA; Jang IJ
    Clin Ther; 2008 Oct; 30(10):1817-30. PubMed ID: 19014837
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Lithium: EEG, performance and mood under subchronic therapy (author's transl)].
    Herrmann WM; Hamann S; Fichte K; Müller-Oerlinghausen B
    Arzneimittelforschung; 1978; 28(9):1520-1. PubMed ID: 582550
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetic and -dynamic studies with a new anxiolytic, suriclone, utilizing EEG mapping and psychometry.
    Saletu B; Grünberger J; Linzmayer L; Semlitsch HV; Anderer P; Chwatal K
    Br J Clin Pharmacol; 1994 Feb; 37(2):145-56. PubMed ID: 7910470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.